Patents by Inventor Matthew John HARRIS

Matthew John HARRIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Radiopharmaceuticals, uses thereof, and methods for the production thereof
    Publication number: 20240050600
    Abstract: Radiopharmaceutical compounds of general Formula (I) are based on a sarcophagine cage having a PEG linker-group X through to a group Y capable of binding to a biological receptor and an albumin-binding group Z for the treatment, diagnosis or imaging of diseases including cancer, and the production of such compounds and their complexes.
    Type: Application
    Filed: August 13, 2021
    Publication date: February 15, 2024
    Applicant: Clarity Pharmaceuticals Ltd
    Inventors: Lachlan Eion MCINNES, Paul Stephen DONNELLY, Ellen Marianne VAN DAM, Matthew John HARRIS
  • FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
    Publication number: 20230330276
    Abstract: Aqueous formulations and kits of radiopharmaceutical compounds of general Formula (II) protected from radiolysis with stabilisers, such as L-methionine and gentisic acid, are disclosed, wherein the compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumour targeting antibodies having functional reactive groups such as trans-cyclooctene, processes of preparing said radioligand formulations, and uses thereof for radioimaging, diagnosing and treating cancer.
    Type: Application
    Filed: June 21, 2023
    Publication date: October 19, 2023
    Inventors: Matthew John HARRIS, Sean LUMB
  • Formulations and kits for radiotherapy and diagnostic imaging
    Patent number: 11738100
    Abstract: Aqueous formulations and kits of radiopharmaceutical compounds of general Formula (II) protected from radiolysis with stabilisers, such as L-methionine and gentisic acid, are disclosed, wherein the compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumour targeting antibodies having functional reactive groups such as trans-cyclooctene, processes of preparing said radioligand formulations, and uses thereof for radioimaging, diagnosing and treating cancer.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: August 29, 2023
    Assignee: CLARITY PHARMACEUTICALS LIMITED
    Inventors: Matthew John Harris, Sean Lumb
  • FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
    Publication number: 20210402013
    Abstract: The present invention relates to formulations of radiolabelled compounds that are of use in radiotherapy and diagnostic imaging.
    Type: Application
    Filed: February 1, 2021
    Publication date: December 30, 2021
    Inventors: Matthew John HARRIS, Ellen Marianne VAN DAM, Charmaine Marie JEFFERY
  • FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
    Publication number: 20210015950
    Abstract: Aqueous formulations and kits of radiopharmaceutical compounds of general Formula (II) protected from radiolysis with stabilisers, such as L-methionine and gentisic acid, are disclosed, wherein the compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumour targeting antibodies having functional reactive groups such as trans-cyclooctene, processes of preparing said radioligand formulations, and uses thereof for radioimaging, diagnosing and treating cancer.
    Type: Application
    Filed: April 11, 2019
    Publication date: January 21, 2021
    Inventors: Matthew John HARRIS, Sean LUMB
  • FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
    Publication number: 20190282715
    Abstract: The present invention relates to formulations of radiolabelled compounds that are of use in radiotherapy and diagnostic imaging.
    Type: Application
    Filed: November 2, 2017
    Publication date: September 19, 2019
    Inventors: Matthew John HARRIS, Ellen Marianne VAN DAM, Charmaine Marie JEFFERY
  • Dispenser for unit dose articles
    Patent number: D1019186
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: March 26, 2024
    Assignee: The Procter & Gamble Company
    Inventors: Kyle William Harris, Nicole Alisa Renee Lockett Turner, Scott David Hochberg, Brian David Andres, Matthew John Boehm, Christian Alexander Zipperer